» Articles » PMID: 31498118

Efficacy of HYADD®4-G Single Intra-discal Injections in a Rabbit Model of Intervertebral Disc Degeneration

Overview
Publisher Sage Publications
Date 2019 Sep 10
PMID 31498118
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Various biomaterials/technologies have been tested for treatment of intervertebral disc (IVD) degeneration (IDD). Only few non-surgical options exist.

Objective: Assessment of efficacy and safety of the hyaluronic acid derivative hydrogel HYADD®4-G in IDD using a well-established rabbit annular puncture model.

Methods: Rabbits were punctured at two IVDs to induce IDD. Thirty days after, IVDs were injected with HYADD®4-G or saline. IVD hydration, height, appearance and tissue organization were assessed by radiographs, MRI and histopathology. Safety of HYADD®4-G injection was evaluated in non-punctured IVDs.

Results: HYADD®4-G injection restored disc height to over 75% of the pre-punctured disc, saline injections led to 50% of initial disc height. Compared to saline, HYADD®4-G treatment resulted in improved water retention as revealed by MRI quantification. 83.3% of HYADD®4-G injected discs had normal appearance and reached grade I of the Pfirrmann scale. Regarding tissue organization and cellularity, HYADD®4-G treatment resulted in significantly lower IDD scores than saline (p < 0.01). HYADD®4-G injected into healthy IVDs did not induce inflammation or foreign body reactions.

Conclusions: Intra-discal HYADD®4-G injection is safe and has therapeutic benefits: IDD could be limited through restoration of disc height and hydration and maintenance of normal IVD tissue organization.

Citing Articles

Orthobiologic Management Options for Degenerative Disc Disease.

de Oliveira C, Oliveira B, Theodoro R, Wang J, Santos G, Rodrigues B Bioengineering (Basel). 2024; 11(6).

PMID: 38927827 PMC: 11200769. DOI: 10.3390/bioengineering11060591.


Hydrogel-Based Strategies for Intervertebral Disc Regeneration: Advances, Challenges and Clinical Prospects.

Desai S, Srinivasan S, Kumbar S, Moss I Gels. 2024; 10(1).

PMID: 38247785 PMC: 10815657. DOI: 10.3390/gels10010062.


Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential .

Antony J, Birrer P, Bohnert C, Zimmerli S, Hillmann P, Schaffhauser H Mol Ther Nucleic Acids. 2023; 34:102055.

PMID: 37928443 PMC: 10622308. DOI: 10.1016/j.omtn.2023.102055.